George Elston
CIK 1429932 · Chief Financial Officer · last filed 2026-05-27
George Elston is a Chief Financial Officer who has filed 35 SEC Form 4 insider transactions across 4 companies since 2008. The most recent filing, for EYPT, was dated May 27, 2026. Across all open-market trades the lifetime net is +$40.3K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.59M
4
35
$40.3K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EYPT | Chief Financial Officer | 121,691 | $13.03 | $1.59M | $34.8K | 24 | 2026-05-27 |
| JUNIPER PHARMACEUTICALS INC (JNP) Delisted | Chief Financial Officer | 1,000 | — | — | $5.5K | 2 | 2016-08-31 |
| JUNIPER PHARMACEUTICALS INC (CBRX) Delisted | Chief Financial Officer | — | — | — | $0 | 1 | 2014-10-03 |
| Celldex Therapeutics, Inc. (AVAN) Delisted | Director | — | $10.04 | — | $0 | 1 | 2008-09-29 |
Recent Filings
35 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-27 | EYPT | Mixed | +3,873 | -$46.9K | EDGAR |
| 2026-03-06 | EYPT | Gift (G) | — | $0 | EDGAR |
| 2026-01-07 | EYPT | Mixed | +10,798 | -$75.7K | EDGAR |
| 2026-01-06 | EYPT | Mixed | +23,940 | -$187.3K | EDGAR |
| 2025-12-23 | EYPT | Gift (G) | — | $0 | EDGAR |
| 2025-09-22 | EYPT | Gift (G) | — | $0 | EDGAR |
| 2025-05-27 | EYPT | Mixed | +5,298 | -$12.5K | EDGAR |
| 2025-02-11 | EYPT | Exer (M) | +5,834 | $0 | EDGAR |
| 2025-01-07 | EYPT | Mixed | +20,210 | -$85.2K | EDGAR |
| 2024-05-28 | EYPT | Mixed | +3,873 | -$40.5K | EDGAR |